Organogenesis spends $6 million on automation:
This article was originally published in Clinica
Executive Summary
Canton, Massachusetts-based Organogenesis has launched a $6 million modification plan to improve its manufacturing facility. The plan includes expanding automation in relation to Apligraf, the company's tissue-engineered product for treating venous leg ulcers.